
Ae1 Ae3 Antibody Bafilomycin A1 Bile Acid Assay Bioassay Blog Choline Acetyltransferase Antibody Deoxycholic Acid Sodium Salt ELISA kit Epz 6438 Hdac Activity Assay immune Isotype Ldn 193189 Mothers Against Decapentaplegic Mouse Albumin Elisa Pamabrom 100Mg Soft Agar Sr 9011 Trypsin Activity Assay Tubastatin A Uric Acid Assay Valproic Acid Sodium Salt Western Blot
Unravelling the selectivity of 6,7 dimethyl Quinoxaline analogues for kinase inhibition: An Insight towards the development of Alzheimer’s therapeutics
Lieven
- 0
Untangling probably the most selective kinase inhibitors by way of pharmacological intervention stays one of many difficult affairs thus far. Inaccordance to this drift, herein we describe the design and synthesis of a set of recent heterocyclic analogues consisting of 6,7 dimethyl Quinoxaline, appended to a connector, using Schiff base technique (Compounds I – IX ).
The compounds had been characterised by numerous spectroscopic strategies and the kinase inhibition assay had been carried out on few prime members of the CMGC household specifically the GSK3 b , DYRK1A and CLK1 receptors respectively, which were identified to be straight concerned in hyperphosphorylation of Tau.
Curiously the organic analysis outcomes revealed that Compounds IV & V , with bromo/chloro functionalities within the fragrant core had been advantaged of being extremely selective in the direction of the goal GSK3b over others.
To strengthen our evaluation, we adopted molecular modelling research, the place compounds IV /V had been redocked in the identical grid 4AFJ, as that of the reference ligand, 5-Aryl-4-Carboxamide-1,3-Oxazole. Surprisingly, our investigation underpined that for each the compounds IV/V, a major H-bonding existed between the designed molecules ( IV/V) and Val 135 residue within the receptor GSK3b, inline with the reference ligand. We attribute this interplay to instigate efficiency within the compounds.
Certainly the opposite non-covalent interplay, between the by-product’s fragrant nucleus and Arg 141/Thr 138 within the receptor GSK3b, might need been answerable for enhancing the selectivity within the targets. Total, we really feel that the current work depicts a logical demonstration in the direction of advantageous tuning the efficacy of the inhibitors by way of systematic adjustment of electron density at acceptable positions within the fragrant ring be it the primary quinoxaline or the opposite fragrant nucleus. Thus this pathway presents a handy technique for the event of environment friendly therapeutics for diversified neurodegenerative ailments like that of Alzheimer’s.
GSK3 as a Regulator of Cytoskeleton Structure: Penalties for Well being and Illness
Glycogen synthase kinase 3 (GSK3) was initially remoted as a vital protein in vitality metabolism. Nonetheless, subsequent research point out that GSK-Three is a multi-tasking kinase that hyperlinks quite a few signaling pathways in a cell and performs an important position within the regulation of many elements of mobile physiology.
As a regulator of actin and tubulin cytoskeleton, GSK3 influences processes of cell polarization, interplay with the extracellular matrix, and directional migration of cells and their organelles throughout the progress and growth of an animal organism. On this assessment, the roles of GSK3-cytoskeleton interactions in mind growth and pathology, migration of wholesome and most cancers cells, and in mobile trafficking of mitochondria shall be mentioned.

An Overview of the Security, Effectivity, and Sign Pathways of Stem Cell Remedy for Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is an autoimmune illness that impacts a number of organs and tissues. Mesenchymal stem cells (MSCs) are thought-about a great supply for autoimmune illness and hematological illness remedy. This assessment will summarize the efficacy, security, and mechanisms of MSC remedy for SLE.
MSC remedy can scale back anti-dsDNA, antinuclear antigen (ANA), proteinuria, and serum creatinine in SLE sufferers. In animal fashions of SLE, MSC remedy additionally signifies that it might scale back anti-dsDNA, ANA, proteinuria, and serum creatinine and ameliorate renal pathology.
There aren’t any severe hostile occasions, treatment-related mortality, or tumor-related occasions in SLE sufferers after stem cell therapy. MSCs can inhibit inflammatory components, equivalent to MCP-1 and HMGB-1, and inhibit inflammation-related signaling pathways, such because the NF-κB, JAK/STAT, and Akt/GSK3β signaling pathways, to alleviate the lesions in SLE.
Mitotic WNT signalling orchestrates neurogenesis within the growing neocortex
The position of WNT/β-catenin signalling in mouse neocortex growth stays ambiguous. Most research reveal that WNT/β-catenin regulates progenitor self-renewal however others counsel it could additionally promote differentiation. Right here we discover the position of WNT/STOP signalling, which stabilizes proteins throughout G2/M by inhibiting glycogen synthase kinase (GSK3)-mediated protein degradation.
We present that mice mutant for cyclin Y and cyclin Y-like 1 (Ccny/l1), key regulators of WNT/STOP signalling, show decreased neurogenesis within the growing neocortex. Particularly, basal progenitors, which exhibit delayed cell cycle development, had been drastically decreased. Ccny/l1-deficient apical progenitors present decreased uneven division attributable to a rise in apical-basal astral microtubules.
We establish the neurogenic transcription components Sox4 and Sox11 as direct GSK3 targets which are stabilized by WNT/STOP signalling in basal progenitors throughout mitosis and that promote neuron technology. Our work reveals that WNT/STOP signalling drives cortical neurogenesis and identifies mitosis as a vital part for neural progenitor destiny.
GSK3s: nodes of multilayer regulation of plant growth and stress responses
Glycogen synthase kinase 3 (GSK3) relations are extremely conserved serine/threonine protein kinases in eukaryotes. Not like animals, vegetation have developed with a number of homologs of GSK3s concerned in a various array of organic processes. Rising proof means that GSK3s act as signaling hubs for integrating notion and transduction of numerous indicators required for plant growth and responses to abiotic and biotic cues.
Right here we assessment current advances in understanding the molecular interactions between GSK3s and an increasing spectrum of their upstream regulators and downstream substrates in vegetation. We additional focus on how GSK3s act as key signaling nodes of multilayer regulation of plant growth and stress response by way of both being regulated on the post-translational degree or regulating their substrates by way of phosphorylation.
A GSK3-SRF Axis Mediates Angiotensin II Induced Endothelin Transcription in Vascular Endothelial Cells
Endothelin, encoded by ET1, is a vasoactive substance primarily synthesized in vascular endothelial cells (VECs). Elevation of endothelin ranges, attributable to transcriptional hyperactivation, has been noticed in a bunch of cardiovascular ailments. We now have beforehand proven that serum response issue (SRF) is a regulator of ET1 transcription in VECs.
Right here we report that angiotensin II (Ang II) induced ET1 transcription paralleled activation of glycogen synthase kinase 3 (GSK3) in cultured VECs. GSK3 knockdown or pharmaceutical inhibition attenuated Ang II induced endothelin expression.

Of curiosity, the impact of GSK3 on endothelin transcription relied on the conserved SRF motif inside the ET1 promoter. Additional evaluation revealed that GSK3 interacted with and phosphorylated SRF at serine 224. Phosphorylation of SRF by GSK3 didn’t affect its recruitment to the ET1 promoter.
As an alternative, GSK3-mediated SRF phosphorylation potentiated its interplay with MRTF-A, a key co-factor for SRF, which helped recruit the chromatin transforming protein BRG1 to the ET1 promoter leading to augmented histone H3 acetylation/H3K4 trimethylation.
GSK3b antibody |
|||
70R-11869 | Fitzgerald | 100 ug | EUR 501.6 |
Description: Rabbit polyclonal GSK3b antibody |
GSK3B antibody |
|||
70R-15005 | Fitzgerald | 100 ul | EUR 470.4 |
Description: Rabbit polyclonal GSK3B antibody |
GSK3B antibody |
|||
70R-17615 | Fitzgerald | 50 ul | EUR 522 |
Description: Rabbit polyclonal GSK3B antibody |
GSK3B Antibody |
|||
36918-100ul | SAB | 100ul | EUR 302.4 |
GSK3B Antibody |
|||
ABD6806 | Lifescience Market | 100 ug | EUR 525.6 |
GSK3B Antibody |
|||
ABD7231 | Lifescience Market | 100 ug | EUR 525.6 |
GSK3B Antibody |
|||
1-CSB-PA009963GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against GSK3B. Recognizes GSK3B from Human, Mouse, Rat, Pig. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
GSK3B Antibody |
|||
1-CSB-PA009963LA01HU | Cusabio |
|
|
Description: A polyclonal antibody against GSK3B. Recognizes GSK3B from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF; Recommended dilution: WB:1:2000-1:10000, IF:1:50-1:500 |
GSK3B Antibody |
|||
1-CSB-PA009038 | Cusabio |
|
|
Description: A polyclonal antibody against GSK3B. Recognizes GSK3B from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/5000 |
GSK3B Antibody |
|||
1-CSB-PA080166 | Cusabio |
|
|
Description: A polyclonal antibody against GSK3B. Recognizes GSK3B from Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC;WB:1:1000-2000.IHC:1:200-500 |
GSK3B Antibody |
|||
CSB-PA939628- | Cusabio | each | EUR 402 |
Description: A polyclonal antibody against GSK3B. Recognizes GSK3B from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
GSK3B Antibody |
|||
CSB-PA939628-100ul | Cusabio | 100ul | EUR 379.2 |
Description: A polyclonal antibody against GSK3B. Recognizes GSK3B from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
GSK3B Antibody |
|||
1-CSB-PA002848 | Cusabio |
|
|
Description: A polyclonal antibody against GSK3B. Recognizes GSK3B from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, IP, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IP:2-5ug/mglysate.ELISA:1/20000 |
GSK3B Antibody |
|||
F51046-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 140.25 |
Description: GSK3B is a constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. May also mediate the development of insulin resistance by regulating activation of transcription factors. [UniProt] |
GSK3B Antibody |
|||
F51046-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 322.15 |
Description: GSK3B is a constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. May also mediate the development of insulin resistance by regulating activation of transcription factors. [UniProt] |
Gsk3b Antibody |
|||
F44221-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 140.25 |
Description: Participates in the Wnt signaling pathway. Implicated in the hormonal control of several regulatory proteins including glycogen synthase, MYB and the transcription factor JUN. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. May phosphorylate MUC1 and decrease the interaction of MUC1 with CTNNB1/beta-catenin. Phosphorylates CTNNB1/beta-catenin. Phosphorylates SNAI1 (By similarity). |
Gsk3b Antibody |
|||
F44221-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 322.15 |
Description: Participates in the Wnt signaling pathway. Implicated in the hormonal control of several regulatory proteins including glycogen synthase, MYB and the transcription factor JUN. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. May phosphorylate MUC1 and decrease the interaction of MUC1 with CTNNB1/beta-catenin. Phosphorylates CTNNB1/beta-catenin. Phosphorylates SNAI1 (By similarity). |
GSK3A / GSK3B Antibody |
|||
20-abx328487 | Abbexa |
|
|
GSK3A/GSK3B Antibody |
|||
1-CSB-PA002838 | Cusabio |
|
|
Description: A polyclonal antibody against GSK3A/GSK3B. Recognizes GSK3A/GSK3B from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/20000 |
GSK3B (pY216) Antibody |
|||
20-abx123289 | Abbexa |
|
|
GSK3B (pY216) Antibody |
|||
20-abx000312 | Abbexa |
|
|
GSK3B Antibody, HRP conjugated |
|||
1-CSB-PA009963LB01HU | Cusabio |
|
|
Description: A polyclonal antibody against GSK3B. Recognizes GSK3B from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
GSK3B Antibody, FITC conjugated |
|||
1-CSB-PA009963LC01HU | Cusabio |
|
|
Description: A polyclonal antibody against GSK3B. Recognizes GSK3B from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
GSK3B Antibody, Biotin conjugated |
|||
1-CSB-PA009963LD01HU | Cusabio |
|
|
Description: A polyclonal antibody against GSK3B. Recognizes GSK3B from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
GSK3B Conjugated Antibody |
|||
C38353 | SAB | 100ul | EUR 476.4 |
GSK3B Conjugated Antibody |
|||
C36918 | SAB | 100ul | EUR 476.4 |
GSK3B Polyclonal Antibody |
|||
A72446 | EpiGentek |
|
|
GSK3B Polyclonal Antibody |
|||
A72447 | EpiGentek |
|
|
GSK3B Polyclonal Antibody |
|||
A72448 | EpiGentek |
|
|
GSK3B Polyclonal Antibody |
|||
A72450 | EpiGentek |
|
|
GSK3B Polyclonal Antibody |
|||
A62706 | EpiGentek |
|
|
GSK3 beta Antibody / GSK3B |
|||
F54007-0.1ML | NSJ Bioreagents | 0.1 ml | EUR 322.15 |
Description: Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. Requires primed phosphorylation of the majority of its substrates. In skeletal muscle, contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. May also mediate the development of insulin resistance by regulating activation of transcription factors. Regulates protein synthesis by controlling the activity of initiation factor 2B (EIF2BE/EIF2B5) in the same manner as glycogen synthase. In Wnt signaling, GSK3B forms a multimeric complex with APC, AXIN1 and CTNNB1/beta-catenin and phosphorylates the N-terminus of CTNNB1 leading to its degradation mediated by ubiquitin/proteasomes. [UniProt] |
GSK3B (Ab-9) Antibody |
|||
CSB-PA120951- | Cusabio | each | EUR 402 |
Description: A polyclonal antibody against GSK3B (Ab-9). Recognizes GSK3B (Ab-9) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:200, IF:1:100-1:200 |
GSK3B (Ab-9) Antibody |
|||
CSB-PA120951-100ul | Cusabio | 100ul | EUR 379.2 |
Description: A polyclonal antibody against GSK3B (Ab-9). Recognizes GSK3B (Ab-9) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:200, IF:1:100-1:200 |
GSK3B (pS21 / 29) Antibody |
|||
abx031864-400ul | Abbexa | 400 ul | EUR 627.6 |
GSK3B (pS21 / 29) Antibody |
|||
abx031864-80l | Abbexa | 80 µl | EUR 343.2 |
Monoclonal GSK3B Antibody, Clone: 3D6B4 |
|||
AMM05223G | Leading Biology | 0.1ml | EUR 633.6 |
Description: A Monoclonal antibody against Human GSK3B. The antibodies are raised in Mouse and are from clone 3D6B4. This antibody is applicable in WB and IHC, FC, E |
Rabbit Anti-Human GSK3B (aa 214-218) Polyclonal Antibody |
|||
CPB-1178RH | Creative Diagnostics | 100 ul | EUR 552 |
GSK3A / GSK3B (pY279 / 216) Antibody |
|||
abx333212-100ul | Abbexa | 100 ul | EUR 560.4 |
GSK3A / GSK3B (pY279 / 216) Antibody |
|||
20-abx328488 | Abbexa |
|
|
Polyclonal Mouse Gsk3b Antibody (N-term) |
|||
APR04027G | Leading Biology | 0.1ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Mouse Gsk3b (N-term). This antibody is tested and proven to work in the following applications: |
Polyclonal GSK3B / GSK3 Beta Antibody |
|||
AMM05221G | Leading Biology | 0.05mg | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GSK3B / GSK3 Beta . This antibody is tested and proven to work in the following applications: |
GSK3A / GSK3B (Ab-279 / 216) Antibody |
|||
abx332166-100ul | Abbexa | 100 ul | EUR 510 |
GSK3A/GSK3B (Ab-279/216) Antibody |
|||
CSB-PA255909- | Cusabio | each | EUR 402 |
Description: A polyclonal antibody against GSK3A/GSK3B (Ab-279/216). Recognizes GSK3A/GSK3B (Ab-279/216) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
GSK3A/GSK3B (Ab-279/216) Antibody |
|||
CSB-PA255909-100ul | Cusabio | 100ul | EUR 379.2 |
Description: A polyclonal antibody against GSK3A/GSK3B (Ab-279/216). Recognizes GSK3A/GSK3B (Ab-279/216) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D | Stressmarq | 0.1ml | EUR 424.8 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is unconjugated. |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D-A390 | Stressmarq | 0.1ml | EUR 481.2 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to ATTO 390. |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D-A488 | Stressmarq | 0.1ml | EUR 480 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to ATTO 488. |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D-A565 | Stressmarq | 0.1ml | EUR 480 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to ATTO 565. |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D-A594 | Stressmarq | 0.1ml | EUR 480 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to ATTO 594. |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D-A633 | Stressmarq | 0.1ml | EUR 480 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to ATTO 633. |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D-A655 | Stressmarq | 0.1ml | EUR 480 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to ATTO 655. |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D-A680 | Stressmarq | 0.1ml | EUR 480 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to ATTO 680. |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D-A700 | Stressmarq | 0.1ml | EUR 480 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to ATTO 700. |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D-ALP | Stressmarq | 0.1ml | EUR 472.8 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to Alkaline Phosphatase. |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D-APC | Stressmarq | 0.1ml | EUR 478.8 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to APC . |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D-APCCY7 | Stressmarq | 0.1ml | EUR 565.2 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to APC/Cy7. |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D-BI | Stressmarq | 0.1ml | EUR 475.2 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to Biotin. |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D-DY350 | Stressmarq | 0.1ml | EUR 496.8 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to Dylight 350. |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D-DY405 | Stressmarq | 0.1ml | EUR 483.6 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to Dylight 405. |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D-DY488 | Stressmarq | 0.1ml | EUR 471.6 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to Dylight 488. |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D-DY594 | Stressmarq | 0.1ml | EUR 474 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to Dylight 594. |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D-DY633 | Stressmarq | 0.1ml | EUR 468 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to Dylight 633. |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D-FITC | Stressmarq | 0.1ml | EUR 470.4 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to FITC. |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D-HRP | Stressmarq | 0.1ml | EUR 465.6 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to HRP. |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D-P594 | Stressmarq | 0.1ml | EUR 488.4 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to PE/ATTO 594. |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D-PCP | Stressmarq | 0.1ml | EUR 478.8 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to PerCP. |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D-RPE | Stressmarq | 0.1ml | EUR 476.4 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to RPE . |
Antibody for Human GSK3b (pSer9) |
|||
SPC-1384D-STR | Stressmarq | 0.1ml | EUR 477.6 |
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to Streptavidin. |
GSK3B Polyclonal Conjugated Antibody |
|||
C30706 | SAB | 100ul | EUR 476.4 |
[KO Validated] GSK3B Polyclonal Antibody |
|||
30706-100ul | SAB | 100ul | EUR 302.4 |
[KO Validated] GSK3B Polyclonal Antibody |
|||
30706-50ul | SAB | 50ul | EUR 224.4 |
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody |
|||
20-abx318062 | Abbexa |
|
|
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody |
|||
abx233673-100ug | Abbexa | 100 ug | EUR 577.2 |
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody |
|||
abx233674-100ug | Abbexa | 100 ug | EUR 577.2 |
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody |
|||
abx233675-100ug | Abbexa | 100 ug | EUR 661.2 |
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody |
|||
abx233676-100ug | Abbexa | 100 ug | EUR 610.8 |
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody |
|||
abx224101-100ug | Abbexa | 100 ug | EUR 493.2 |
Glycogen Synthase Kinase 3 Beta (GSK3b) Antibody |
|||
20-abx176674 | Abbexa |
|
|
Glycogen Synthase Kinase 3 Beta (GSK3b) Antibody |
|||
20-abx176675 | Abbexa |
|
|
Glycogen Synthase Kinase 3 Beta (GSK3b) Antibody |
|||
20-abx172635 | Abbexa |
|
|
Glycogen Synthase Kinase 3 Beta (GSK3b) Antibody |
|||
20-abx172636 | Abbexa |
|
|
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody |
|||
abx147405-100ug | Abbexa | 100 ug | EUR 526.8 |
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody |
|||
abx332790-100ul | Abbexa | 100 ul | EUR 510 |
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody |
|||
20-abx330217 | Abbexa |
|
|
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody |
|||
abx332014-100ul | Abbexa | 100 ul | EUR 510 |
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody |
|||
20-abx112808 | Abbexa |
|
|
Glycogen Synthase Kinase 3 Beta (Gsk3b) Antibody |
|||
abx028354-400ul | Abbexa | 400 ul | EUR 627.6 |
Glycogen Synthase Kinase 3 Beta (Gsk3b) Antibody |
|||
abx028354-80l | Abbexa | 80 µl | EUR 343.2 |
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody |
|||
abx037712-100ug | Abbexa | 100 ug | EUR 469.2 |
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody |
|||
20-abx125048 | Abbexa |
|
|
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody |
|||
20-abx125336 | Abbexa |
|
|
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody |
|||
20-abx125917 | Abbexa |
|
|
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody |
|||
20-abx328988 | Abbexa |
|
|
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody |
|||
20-abx329709 | Abbexa |
|
|
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody |
|||
20-abx001694 | Abbexa |
|
|
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody |
|||
20-abx002277 | Abbexa |
|
|
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody |
|||
20-abx004714 | Abbexa |
|
|
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody |
|||
abx010856-100ul | Abbexa | 100 ul | EUR 493.2 |
Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody |
|||
20-abx134166 | Abbexa |
|
|
Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody |
|||
20-abx121488 | Abbexa |
|
|
Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody |
|||
20-abx445135 | Abbexa |
|
|
Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody |
|||
abx033884-400ul | Abbexa | 400 ul | EUR 627.6 |
Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody |
|||
abx033884-80l | Abbexa | 80 µl | EUR 343.2 |
Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody |
|||
20-abx000728 | Abbexa |
|
|
GSK3B Polyclonal Antibody, HRP Conjugated |
|||
A62707 | EpiGentek |
|
|
GSK3B Polyclonal Antibody, FITC Conjugated |
|||
A62708 | EpiGentek |
|
|
Phospho-GSK3A/GSK3B (Y279/216) Antibody |
|||
1-CSB-PA000535 | Cusabio |
|
|
Description: A polyclonal antibody against Phospho-GSK3A/GSK3B (Y279/216). Recognizes Phospho-GSK3A/GSK3B (Y279/216) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/20000 |
Rabbit Anti-Human GSK3B Polyclonal Antibody, Phospho-Tyr216 |
|||
CPB-820RH | Creative Diagnostics | 100 ul | EUR 670.8 |
Anti-Glycogen synthase kinase 3 B (GSK3B) (Ser9) antibody |
|||
STJ120111 | St John's Laboratory | 100 µl | EUR 631.2 |
GSK3B Polyclonal Antibody, Biotin Conjugated |
|||
A62709 | EpiGentek |
|
|
Phospho-GSK3A/GSK3B (Tyr279/216) Antibody |
|||
CSB-PA575559- | Cusabio | each | EUR 402 |
Description: A polyclonal antibody against Phospho-GSK3A/GSK3B (Tyr279/216). Recognizes Phospho-GSK3A/GSK3B (Tyr279/216) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:100, IF:1:100-1:200 |
Phospho-GSK3A/GSK3B (Tyr279/216) Antibody |
|||
CSB-PA575559-100ul | Cusabio | 100ul | EUR 434.4 |
Description: A polyclonal antibody against Phospho-GSK3A/GSK3B (Tyr279/216). Recognizes Phospho-GSK3A/GSK3B (Tyr279/216) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:100, IF:1:100-1:200 |
Rabbit Anti-GSK3A, GSK3B monoclonal antibody, clone TZ37-16 |
|||
CABT-L635 | Creative Diagnostics | 100 ul | EUR 932.4 |
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody (HRP) |
|||
20-abx304084 | Abbexa |
|
|
Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (ALP) |
|||
abx445506-100ug | Abbexa | 100 ug | EUR 610.8 |
Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (APC) |
|||
abx445507-100ug | Abbexa | 100 ug | EUR 627.6 |
Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (RPE) |
|||
abx445513-100ug | Abbexa | 100 ug | EUR 627.6 |
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody (FITC) |
|||
20-abx304085 | Abbexa |
|
|
Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (PerCP) |
|||
abx445512-100ug | Abbexa | 100 ug | EUR 627.6 |
Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody (Biotin) |
|||
20-abx304086 | Abbexa |
|
|
Polyclonal GSK3B / GSK3 Beta Antibody (C-Terminus) |
|||
AMM05222G | Leading Biology | 0.05mg | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GSK3B / GSK3 Beta (C-Terminus). This antibody is tested and proven to work in the following applications: |
Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (ATTO 390) |
|||
abx445498-100ug | Abbexa | 100 ug | EUR 627.6 |
Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (ATTO 488) |
|||
abx445499-100ug | Abbexa | 100 ug | EUR 627.6 |
Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (ATTO 565) |
|||
abx445500-100ug | Abbexa | 100 ug | EUR 627.6 |
Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (ATTO 594) |
|||
abx445501-100ug | Abbexa | 100 ug | EUR 627.6 |
Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (ATTO 633) |
|||
abx445502-100ug | Abbexa | 100 ug | EUR 627.6 |
Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (ATTO 655) |
|||
abx445503-100ug | Abbexa | 100 ug | EUR 627.6 |
Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (ATTO 680) |
|||
abx445504-100ug | Abbexa | 100 ug | EUR 627.6 |
Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (ATTO 700) |
|||
abx445505-100ug | Abbexa | 100 ug | EUR 627.6 |
Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (Streptavidin) |
|||
abx445514-100ug | Abbexa | 100 ug | EUR 627.6 |
Glycogen synthase kinase-3 beta Antibody / GSK3B |
|||
RQ7291 | NSJ Bioreagents | 100ug | EUR 419 |
Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (PE/ATTO 594) |
|||
abx445511-100ug | Abbexa | 100 ug | EUR 644.4 |
Glycogen Synthase Kinase 3 Beta (GSK3b) Polyclonal Antibody (Human) |
|||
4-PAD317Hu01 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Glycogen Synthase Kinase 3 Beta (GSK3b) |
GSK3B siRNA |
|||
20-abx918789 | Abbexa |
|
|
GSK3B siRNA |
|||
20-abx918790 | Abbexa |
|
|
GSK3B siRNA |
|||
20-abx902344 | Abbexa |
|
|
GSK3B Plasmid |
|||
PVT7113 | Lifescience Market | 2 ug | EUR 319.2 |
Glycogen Synthase Kinase 3 Beta Phospho-Ser9 (GSK3B pS9) Antibody |
|||
abx333187-100ul | Abbexa | 100 ul | EUR 560.4 |
Glycogen Synthase Kinase 3 Beta Phospho-Ser9 (GSK3B pS9) Antibody |
|||
20-abx328236 | Abbexa |
|
|
Glycogen Synthase Kinase 3 Beta Phospho-Ser9 (GSK3B pS9) Antibody |
|||
20-abx329723 | Abbexa |
|
|
Glycogen Synthase Kinase-3 Beta Phospho-Ser9 (GSK3B pS9) Antibody |
|||
abx411895-01ml | Abbexa | 0.1 ml | EUR 844.8 |
Glycogen Synthase Kinase 3 Beta (GSK3b) Polyclonal Antibody (Human), PE |
|||
4-PAD317Hu01-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Glycogen Synthase Kinase 3 Beta (GSK3b). This antibody is labeled with PE. |
Glycogen Synthase Kinase 3 Beta (GSK3b) Polyclonal Antibody (Human), APC |
|||
4-PAD317Hu01-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Glycogen Synthase Kinase 3 Beta (GSK3b). This antibody is labeled with APC. |
Glycogen Synthase Kinase 3 Beta (GSK3b) Polyclonal Antibody (Human), Cy3 |
|||
4-PAD317Hu01-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Glycogen Synthase Kinase 3 Beta (GSK3b). This antibody is labeled with Cy3. |
Glycogen Synthase Kinase 3 Beta (GSK3b) Polyclonal Antibody (Human), HRP |
|||
4-PAD317Hu01-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Glycogen Synthase Kinase 3 Beta (GSK3b). This antibody is labeled with HRP. |
Glycogen Synthase Kinase 3 Beta (GSK3b) Polyclonal Antibody (Human), FITC |
|||
4-PAD317Hu01-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Glycogen Synthase Kinase 3 Beta (GSK3b). This antibody is labeled with FITC. |
pT7- His- GSK3B |
|||
PVT10128 | Lifescience Market | 2 ug | EUR 361.2 |
Glycogen Synthase Kinase 3 Beta (GSK3b) Polyclonal Antibody (Human), APC-Cy7 |
|||
4-PAD317Hu01-APC-Cy7 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Glycogen Synthase Kinase 3 Beta (GSK3b). This antibody is labeled with APC-Cy7. |
Glycogen Synthase Kinase 3 Beta (GSK3b) Polyclonal Antibody (Human), Biotinylated |
|||
4-PAD317Hu01-Biotin | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Glycogen Synthase Kinase 3 Beta (GSK3b). This antibody is labeled with Biotin. |
GSK3B Rabbit mAb |
|||
A10877-100ul | Abclonal | 100 ul | EUR 460.8 |
GSK3B Rabbit mAb |
|||
A10877-200ul | Abclonal | 200 ul | EUR 664.8 |
GSK3B Rabbit mAb |
|||
A10877-20ul | Abclonal | 20 ul | Ask for price |
GSK3B Rabbit mAb |
|||
A10877-50ul | Abclonal | 50 ul | EUR 318 |
GSK3B Rabbit pAb |
|||
A11360-100ul | Abclonal | 100 ul | EUR 369.6 |
GSK3B Rabbit pAb |
|||
A11360-200ul | Abclonal | 200 ul | EUR 550.8 |
GSK3B Rabbit pAb |
|||
A11360-20ul | Abclonal | 20 ul | EUR 219.6 |
GSK3B Rabbit pAb |
|||
A11360-50ul | Abclonal | 50 ul | EUR 267.6 |
GSK3B Rabbit pAb |
|||
A11578-100ul | Abclonal | 100 ul | EUR 369.6 |
GSK3B Rabbit pAb |
|||
A11578-200ul | Abclonal | 200 ul | EUR 550.8 |
GSK3B Rabbit pAb |
|||
A11578-20ul | Abclonal | 20 ul | EUR 219.6 |
GSK3B Rabbit pAb |
|||
A11578-50ul | Abclonal | 50 ul | EUR 267.6 |
GSK3B Rabbit pAb |
|||
A16868-100ul | Abclonal | 100 ul | EUR 369.6 |
GSK3B Rabbit pAb |
|||
A16868-200ul | Abclonal | 200 ul | EUR 550.8 |
GSK3B Rabbit pAb |
|||
A16868-20ul | Abclonal | 20 ul | EUR 219.6 |
GSK3B Rabbit pAb |
|||
A16868-50ul | Abclonal | 50 ul | EUR 267.6 |
GSK3B Rabbit pAb |
|||
A3174-100ul | Abclonal | 100 ul | EUR 369.6 |
GSK3B Rabbit pAb |
|||
A3174-200ul | Abclonal | 200 ul | EUR 550.8 |
GSK3B Rabbit pAb |
|||
A3174-20ul | Abclonal | 20 ul | EUR 219.6 |
GSK3B Rabbit pAb |
|||
A3174-50ul | Abclonal | 50 ul | EUR 267.6 |
GSK3B Rabbit pAb |
|||
A2081-100ul | Abclonal | 100 ul | EUR 369.6 |
GSK3B Rabbit pAb |
|||
A2081-200ul | Abclonal | 200 ul | EUR 550.8 |
GSK3B Rabbit pAb |
|||
A2081-20ul | Abclonal | 20 ul | EUR 219.6 |
GSK3B Rabbit pAb |
|||
A2081-50ul | Abclonal | 50 ul | EUR 267.6 |
GSK3B cloning plasmid |
|||
CSB-CL009963HU-10ug | Cusabio | 10ug | EUR 568.8 |
Description: A cloning plasmid for the GSK3B gene. |
GSK3B Blocking Peptide |
|||
BF0695-BP | Affbiotech | 1mg | EUR 234 |
GSK3b Blocking Peptide |
|||
33R-10782 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GSK3b antibody, catalog no. 70R-11869 |
GSK3B Blocking Peptide |
|||
DF7231-BP | Affbiotech | 1mg | EUR 234 |
Recombinant Human GSK3B |
|||
P0221 | FN Test | 100ug | EUR 626.83 |
Description: Recombinant Human protein for GSK3B |
pECMV- 3*Flag- GSK3B |
|||
PVT10270 | Lifescience Market | 2 ug | EUR 361.2 |
GSK3B protein (His tag) |
|||
80R-3636 | Fitzgerald | 50 ug | EUR 522 |
Description: Purified recombinant GSK3B protein (His tag) |
Human GSK3B ELISA Kit |
|||
ELA-E2298h | Lifescience Market | 96 Tests | EUR 988.8 |
Rat GSK3B shRNA Plasmid |
|||
20-abx986899 | Abbexa |
|
|
Human GSK3B shRNA Plasmid |
|||
20-abx951981 | Abbexa |
|
|
Mouse GSK3B shRNA Plasmid |
|||
20-abx974854 | Abbexa |
|
|
GSK3B Recombinant Protein (Rat) |
|||
RP203810 | ABM | 100 ug | Ask for price |
GSK3B Recombinant Protein (Mouse) |
|||
RP140201 | ABM | 100 ug | Ask for price |
GSK3B Recombinant Protein (Human) |
|||
RP061362 | ABM | 100 ug | Ask for price |
Gsk3b ORF Vector (Rat) (pORF) |
|||
ORF067938 | ABM | 1.0 ug DNA | EUR 607.2 |
GSK-3b Antibody |
|||
3494-100 | Biovision | each | EUR 392.4 |
GSK-3b Antibody |
|||
3494-30T | Biovision | each | EUR 175.2 |
GSK3B ORF Vector (Human) (pORF) |
|||
ORF020455 | ABM | 1.0 ug DNA | EUR 486 |
Gsk3b ORF Vector (Mouse) (pORF) |
|||
ORF046735 | ABM | 1.0 ug DNA | EUR 607.2 |
[KO Validated] GSK3B Rabbit pAb |
|||
A6164-100ul | Abclonal | 100 ul | EUR 492 |
[KO Validated] GSK3B Rabbit pAb |
|||
A6164-200ul | Abclonal | 200 ul | EUR 685.2 |
[KO Validated] GSK3B Rabbit pAb |
|||
A6164-20ul | Abclonal | 20 ul | EUR 265.2 |
[KO Validated] GSK3B Rabbit pAb |
|||
A6164-50ul | Abclonal | 50 ul | EUR 344.4 |
GSK3B ELISA Kit (Rat) (OKEH03023) |
|||
OKEH03023 | Aviva Systems Biology | 96 Wells | EUR 841.2 |
Description: Description of target: Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. Requires primed phosphorylation of the majority of its substrates. In skeletal muscle, contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. May also mediate the development of insulin resistance by regulating activation of transcription factors. Regulates protein synthesis by controlling the activity of initiation factor 2B (EIF2BE/EIF2B5) in the same manner as glycogen synthase. In Wnt signaling, GSK3B forms a multimeric complex with APC, AXIN1 and CTNNB1/beta-catenin and phosphorylates the N-terminus of CTNNB1 leading to its degradation mediated by ubiquitin/proteasomes. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates NFATC1/NFATC on conserved serine residues promoting NFATC1/NFATC nuclear export, shutting off NFATC1/NFATC gene regulation, and thereby opposing the action of calcineurin. Phosphorylates MAPT/TAU on 'Thr-548', decreasing significantly MAPT/TAU ability to bind and stabilize microtubules. Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. Phosphorylates MACF1, inhibiting its binding to microtubules which is critical for its role in bulge stem cell migration and skin wound repair. Probably regulates NF-kappa-B (NFKB1) at the transcriptional level and is required for the NF-kappa-B-mediated anti-apoptotic response to TNF-alpha (TNF/TNFA). Negatively regulates replication in pancreatic beta-cells, resulting in apoptosis, loss of beta-cells. Through phosphorylation of the anti-apoptotic protein MCL1, may control cell apoptosis in response to growth factors deprivation. Phosphorylates MUC1 in breast cancer cells, decreasing the interaction of MUC1 with CTNNB1/beta-catenin. Is necessary for the establishment of neuronal polarity and axon outgrowth. Phosphorylates MARK2, leading to inhibit its activity. Phosphorylates SIK1 at 'Thr-182', leading to sustain its activity. Phosphorylates ZC3HAV1 which enhances its antiviral activity. Phosphorylates SFPQ upon T-cell activation. Phosphorylates SNAI1, leading to its BTRC-triggered ubiquitination and proteasomal degradation. Phosphorylates NR1D1 st 'Ser-55' and 'Ser-59' and stabilizes it by protecting it from proteasomal degradation. Regulates the circadian clock via phosphorylation of the major clock components including ARNTL/BMAL1, CLOCK and PER2. Phosphorylates CLOCK AT 'Ser-427' and targets it for proteasomal degradation. Phosphorylates ARNTL/BMAL1 at 'Ser-17' and 'Ser-21' and primes it for ubiquitination and proteasomal degradation. Phosphorylates OGT at 'Ser-3' or 'Ser-4' which positively regulates its activity.3 Publications;Species reactivity: Rat;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.172 ng/mL |
GSK3B ELISA Kit (Human) (OKCD08452) |
|||
OKCD08452 | Aviva Systems Biology | 96 Wells | EUR 1170 |
Description: Description of target: Glycogen synthase kinase-3 (GSK3) is a proline-directed serine-threonine kinase that was initially identified as a phosphorylating and inactivating glycogen synthase. Two isoforms, alpha (GSK3A) and beta, show a high degree of amino acid homology. GSK3B is involved in energy metabolism, neuronal cell development, and body pattern formation.Glycogen synthase kinase-3 (GSK3) is a proline-directed serine-threonine kinase that was initially identified as a phosphorylating and inactivating glycogen synthase. Two isoforms, alpha (GSK3A; MIM 606784) and beta, show a high degree of amino acid homology (Stambolic and Woodgett, 1994.). GSK3B is involved in energy metabolism, neuronal cell development, and body pattern formation (Plyte et al., 1992.)... Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 0.227ng/mL |
×
Constantly, over-expression of a constitutively energetic GSK enhanced Ang II-induced ET1 transcription and knockdown of both MRTF-A or BRG1 abrogated the enhancement of ET1 transcription. In conclusion, our information spotlight a beforehand unrecognized mechanism that contributes to the transcriptional regulation of endothelin. Concentrating on this GSK3-SRF axis could yield novel approaches within the intervention of cardiovascular ailments.
Tags: blunt vector cellbiolabs cloning bacterial plasmid crispr cas9 nickase dna mini prep eurofin primers gibson assembly cloning kit ihc counterstain ligation-independent cloning m13 vectors med chem express p bluescript vector p53 shrna pcr 2.1topo pcr4 topo map pdnr pegfp 1 vector pet 41a pet21b vector pet28a plasmid map pet30 vector pgem sequence pgemt vector pgl4 10 pglo restriction map phi 29 polymerase pjg4-5 plko.1 puro ppiczalpha prseta pshuttle psv plasmid puromycin resistance gene pvl1392 sal1 neb